
SB242235

* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS No. | 193746-75-7 | Cat. No. | BCP05992 |
Name | SB242235 | ||
Synonyms | SB-242235;SB 242235; | ||
SMILES | |||
Chemical Name | |||
Formula | C19H20FN5O | M. Wt | 353.39 |
Purity | 98% | Storage | Store at 4-8°C |
Description | in vitro: SB 242235 inhibited intracellular p38 activity, human chondrocytes were treated with different doses of SB 242235 prior to stimulation with IL-1_ for 15 min. MAPKAP K2 was then isolated from these cells and assayed using HSP27 as a substrate. SB 242235 dose-dependently inhibited the activation of MAPKAP K2 with an IC50 of 1.0 uM . in vivo: SB-242235 demonstrates generally favourable pharmacokinetic properties in all species examined(including rat, dog and monkey). Systemic plasma clearance was high in rat, but in the non-rodent species SB-242235 demonstrated low to moderate clearance with plasma half-lives > 4h. Oral bioavailability in each preclinical species was high. In rat and monkey, SB-242235 demonstrated non-linear elimination kinetics that manifested as a decrease in clearance with increasing dose and apparent oral bioavailability > 100% at high oral doses .In the skin of SKH-1 hairless mice, SB242235, prior to UVB irradiation, blocked activation of the p38 MAPK casca |
Recommend Products
More >
-
(S)-(-)-PH-797804
Cat. No.:BCP49370
No.:1358027-80-1
Product Details -
Exarafenib
Cat. No.:BCP49200
No.:2639957-39-2
Product Details -
p38-α MAPK inhibitor 1
Cat. No.:BCP48493
No.:443913-15-3
Product Details -
-
SB-747651A
Cat. No.:BCP46274
No.:607372-46-3
Product Details -
SB-747651A dihydrochloride
Cat. No.:BCP46273
No.:1781882-72-1
Product Details -
PF-05381941
Cat. No.:BCP45842
No.:1474022-02-0
Product Details -
-
-
MW-150 dihydrochloride dihydrate
Cat. No.:BCP30837
No.:1661020-92-3
Product Details -
ITX-5061 HCl
Cat. No.:BCP30784
No.:1252679-52-9
Product Details -
-
-
SB 203580 hydrochloride
Cat. No.:BCP29070
No.:869185-85-3
Product Details -
FR 167653 sulfate
Cat. No.:BCP25927
No.:158876-66-5
Product Details -
-
Pexmetinib
Cat. No.:BCP28410
No.:945614-12-0
Product Details -
-
-
SB202190 HCl
Cat. No.:BCP21617
No.:350228-36-3
Product Details

Tags:SB242235 supplier,SB242235 purchase,SB242235 manufacturer,SB242235 distributor,SB242235 cost,SB242235 buy,SB242235 for sale